Modulation of the Antidepressant Effects of Ketamine by the mTORC1 Inhibitor Rapamycin

Neuropsychopharmacology - United Kingdom
doi 10.1038/s41386-020-0644-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Correction: An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1.

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2020English

Rapamycin Resistance: mTORC1 Substrates Hold Some of the Answers

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2013English

Stress-Sensitive Antidepressant-Like Effects of Ketamine in the Mouse Forced Swim Test

PLoS ONE
Multidisciplinary
2019English

NMDAR Inhibition-Independent Antidepressant Actions of Ketamine Metabolites

European Neuropsychopharmacology
PsychiatryMental HealthNeurologyBiological PsychiatryPharmacology
2017English

Rapid Antidepressant Effect of Ketamine Correlates With Astroglial Plasticity in the Hippocampus

British Journal of Pharmacology
Pharmacology
2017English

Antidepressant-Like Effects of LPM580153, a Novel Potent Triple Reuptake Inhibitor

Scientific Reports
Multidisciplinary
2016English

Potentiation of the Anticancer Effects of Everolimus Using a Dual mTORC1/2 Inhibitor in Hepatocellular Carcinoma Cells

Oncotarget
Oncology
2016English

Modulation of the Mammalian Target of Rapamycin Pathway by Diacylglycerol Kinase-Produced Phosphatidic Acid

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Modulation of Apoptosis by the Cyclin-Dependent Kinase Inhibitor P27Kip1

Journal of Clinical Investigation
Medicine
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy